Suppr超能文献

[日本医院制剂证据数据库建设的文献综述]

[Survey of Literature on the Development of an Evidence Database for Hospital-prepared Drugs in Japan].

作者信息

Momo Kenji

机构信息

Faculty of Pharmaceutical Sciences, Teikyo Heisei University.

出版信息

Yakugaku Zasshi. 2018;138(6):753-756. doi: 10.1248/yakushi.17-00184-1.

Abstract

Hospital-prepared drugs (HP), known as In'Naiseizai in Japan, are custom-prepared formulations which offer medical professionals an alternative administration pathway by changing the formulation of existing drugs according to a patients' needs. Preparing the HP is one of several roles of pharmacists in providing personalized medicine at hospitals in Japan. In 2012, the Japanese Society of Hospital Pharmacists provided guidelines for the appropriate use of "Hospital-prepared drugs". The following information was included in this guide: 1) documentation of the proper procedures, materials, prescription practices, etc., 2) required approval from the institutional review board of each HP on the risk-based classifications, and 3) to assess the stability, efficacy, and safety of each HP. However, several problems persist for pharmacists trying to prepare or use HP appropriately; the most common is insufficient manpower to both assess and prepare these drugs during routine hospital work. To resolve this problem, we are developing an evidence database for HP based on surveys of the current literature. This database has been developed for 109 drugs to date. Data-driven assessment of the stability of HP showed that 52 out of 109 drugs examined (47.7%). Notably, only 6 of the 109 HP (5.5%) in the database had all three characteristics of "stability", "safety", and "efficacy". In conclusion, the application of this database will save manpower hours for hospital pharmacists in the preparation of HP. In the near future, we will make this database available to the wider medical community via the web or through literature.

摘要

医院制剂(HP),在日本被称为“院内制剂”,是定制的制剂,通过根据患者需求改变现有药物的剂型,为医学专业人员提供了另一种给药途径。制备医院制剂是日本医院药剂师在提供个性化药物方面的多项职责之一。2012年,日本医院药剂师协会发布了“医院制剂”合理使用指南。本指南包含以下信息:1)正确程序、材料、处方规范等的文件记录;2)每种医院制剂需经机构审查委员会基于风险分类的批准;3)评估每种医院制剂的稳定性、有效性和安全性。然而,药剂师在试图合理制备或使用医院制剂时仍存在一些问题;最常见的是在日常医院工作中评估和制备这些药物的人力不足。为解决这一问题,我们正在基于对现有文献的调查开发一个医院制剂证据数据库。截至目前,该数据库已针对109种药物建立。基于数据的医院制剂稳定性评估显示,在所检查的109种药物中有52种(47.7%)。值得注意的是,数据库中的109种医院制剂中只有6种(5.5%)具备 “稳定性”“安全性” 和 “有效性” 这三个特征。总之,该数据库的应用将为医院药剂师在制备医院制剂时节省人力时间。在不久的将来,我们将通过网络或文献将这个数据库提供给更广泛的医学界。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验